賢豐控股(002141.SZ):收回資金合計約656.128萬美元
格隆匯 12 月 30日丨賢豐控股(002141.SZ)披露併購基金投資的進展,香港蓉勝於近日通過大宗交易方式先後出售所持SNK部分KDR股份186,509股、218,864股,此次出售後香港蓉勝仍持有SNK的KDR股份619,289股(持股比例為2.94%),此次出售預計為公司2020年度貢獻正向收益金額約1364.67萬元,相應減少公司2020年度虧損金額約1364.67萬元。
此次出售股份公司收回資金分別為2,981,342.1美元、3,579,938.3美元(以2020年12月29日、12月30日美元對人民幣匯率6.5451、6.5325摺合人民幣分別約19,513,182.18元、23,385,946.94元),增強了公司資金的流動性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.